Identification and characterization of functional CD154 (CD40 ligand) in the Pekin duck

Developmental and Comparative Immunology

Volumn 31, Issue 1, 2007, Pages 61-71

  Fischer, Karl P ^a   Gares, Sheryl L ^c   Wang, Dakun ^b   Lorne Tyrrell, D ^a   Gutfreund, Klaus S ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ViRexx Medical Corporation   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cd154; Cd40 ligand; Immunoregulation; Pekin duck; Proliferation; Splenocyte

Indexed keywords

CD40 LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHYTOHEMAGGLUTININ;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; BASE PAIRING; CELL CULTURE; CONTROLLED STUDY; DUCK; DUODENUM; GENE ISOLATION; GENE SEQUENCE; IMMUNE SYSTEM; IMMUNOCHEMISTRY; IMMUNOGENETICS; IMMUNOREGULATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPLEEN; SPLEEN CELL; THYMUS;

ANAS PLATYRHYNCHOS; AVES; MAMMALIA;

EID: 33749118498     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2006.05.001     Document Type: Article

References (32)

1. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 4 (2001) 487-501
2. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 27 1 (2002) 19-26
3. Roy M., Waldschmidt T., Aruffo A., Ledbetter J.A., and Noelle R.J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 151 5 (1993) 2497-2510
4. Higuchi T., Aiba Y., Nomura T., Matsuda J., Mochida K., Suzuki M., et al. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 168 1 (2002) 9-12
5. Schönbeck U., Mach F., and Libby P. CD154 (CD40 ligand). Int J Biochem Cell Biol 32 7 (2000) 687-693
6. Mach F., Schonbeck U., Sukhova G.K., Bourcier T., Bonnefoy J.Y., Pober J.S., et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 94 5 (1997) 1931-1936
7. Fanslow W.C., Srinivasan S., Paxton R., Gibson M.G., Spriggs M.K., and Armitage R.J. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 6 5 (1994) 267-278
8. Graf D., Muller S., Korthauer U., Van Kooten C., Weise C., and Kroczek R.A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25 6 (1995) 1749-1754
9. Pullen S.S., Labadia M.E., Ingraham R.H., McWhirter S.M., Everdeen D.S., Alber T., et al. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization. Biochemistry 38 31 (1999) 10168-10177
10. Armitage R.J. Tumor necrosis factor receptor superfamily members and their ligands. Curr Opin Immunol 6 3 (1994) 407-413
11. Van Kooten C., and Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9 3 (1997) 330-337
12. Bourgeois C., Rocha B., and Tanchot C. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297 5589 (2002) 2060-2063
13. Garside P., Ingulli E., Merica R.R., Johnson J.G., Noelle R.J., and Jenkins M.K. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281 5373 (1998) 96-99
14. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 5097 (1993) 990-993
15. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., and de Saint B.G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361 6412 (1993) 541-543
16. Korthauer U., Graf D., Mages H.W., Briere F., Padayachee M., Malcolm S., et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 6412 (1993) 539-541
17. Castle B.E., Kishimoto K., Stearns C., Brown M.L., and Kehry M.R. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol 151 4 (1993) 1777-1788
18. Moodycliffe A.M., Shreedhar V., Ullrich S.E., Walterscheid J., Bucana C., Kripke M.L., et al. CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 191 11 (2000) 2011-2020
19. Esche C., Gambotto A., Satoh Y., Gerein V., Robbins P.D., Watkins S.C., et al. CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth. Eur J Immunol 29 7 (1999) 2148-2155
20. Quezada S.A., Jarvinen L.Z., Lind E.F., and Noelle R.J. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 22 (2004) 307-328
21. Diehl L., den Boer A.T., van der Voort E.I., Melief C.J., Offringa R., and Toes R.E. The role of CD40 in peripheral T cell tolerance and immunity. J Mol Med 78 7 (2000) 363-371
22. Daoussis D., Andonopoulos A.P., and Liossis S.N. Targeting CD40L: a promising therapeutic approach. Clin Diagn Lab Immunol 11 4 (2004) 635-641
23. Fischer K.P., and Tyrrell D.L. Generation of duck hepatitis B virus polymerase mutants through site-directed mutagenesis which demonstrate resistance to lamivudine [(-)-beta-L-2′, 3′-dideoxy-3′-thiacytidine] in vitro. Antimicrob Agents Chemother 40 8 (1996) 1957-1960
24. Trejbalova K., Gebhard K., Vernerova Z., Dusek L., Geryk J., Hejnar J., et al. Proviral load and expression of avian leukosis viruses of subgroup C in long-term persistently infected heterologous hosts (ducks). Arch Virol 144 9 (1999) 1779-1807
25. Walters K.A., Joyce M.A., Addison W.R., Fischer K.P., and Tyrrell D.L. Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen. J Virol 78 15 (2004) 7925-7937
26. Higgins D.A., and Teoh C.S. Duck lymphocytes. II. Culture conditions for optimum transformation response to phytohaemagglutinin. J Immunol Methods 106 1 (1988) 135-145
27. Vickery K., Cossart Y., Gu X., and Dixon R. Antigen-specific blastogenesis assays for duck hepatitis B virus using duck peripheral blood and splenic mononuclear cells. Vet Immunol Immunopath 59 3-4 (1997) 349-358
28. Harlow E., Lane D., editors., Antibodies-a laboratory manual, Cold Spring Harbor Laboratory Press; 1988.
29. Ford G.S., Barnhart B., Shone S., and Covey L.R. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J Immunol 162 7 (1999) 4037-4044
30. Tregaskes C.A., Glansbeek H.L., Gill A.C., Hunt L.G., Burnside J., and Young JR. Conservation of biological properties of the CD40 ligand, CD154 in a non-mammalian vertebrate. Dev Comp Immunol 29 4 (2005) 361-374
31. Karpusas M., Hsu Y.M., Wang J.H., Thompson J., Lederman S., Chess L., et al. 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3 10 (1995) 1031-1039
32. Gares SL, Fischer KP, Congly S, Lacoste S, Addison WR, Tyrrell DL, et al. Immunotargetting with CD154 (CD40 ligand) fusion proteins enhances DNA vaccine responses in ducks. 2006, Clinical and Vaccine Immunology, in press, doi:10.1128/CVI.00080-06.